References
- Holders of Approved Drug Applications for Drugs presenting Actual or Potential Bioequivalence Problems. New Publication No.76–3009 (FDA), Jan., 1976
- Solomon H. Drug. Inform.Bull. 1969; 3: 75
- Martin C. M. Drug. Inform.Bull. 1969; 3: 72
- Kaplan S. A., Weinfold R. E., Abruzzo C. W., Lewis M. J. Pharm.Sci. 1972; 6l: 773
- Cohen M., Pocelinko R. J. Pharmac.Exp.Ther. 1973; 185: 703
- Garrett E. R., SueverKrup R. S., Eberst K., Yost R. L., O'leary J. P. Biopharm.Drug. Dispos 1981; 2: 329
- Reimerdes E., Thumin J. H. Arzneim-Forsch (Drug Res.) 1970; 20: 1171
- Oeie S. Int.J. Pharm. 1979; 3: 311
- Eung-Ki Shim, Lee H. B., Kim K. S., Kang C. S., Kim H. J. Kungnip Pogon Yon'guwonpo 1978; 15: 331
- Kassem M. A., El Ridy M. S., Gad Z., Khairy L. M., Bull N. R.C. Cairo, Egypt. 1984, Accepted for Publication
- Bratton A. C., Marshall E. K. J. Biol.Chem. 1939; 128: 537
- Whyatt, P.L., Schyrwka, G.W.A., Malikian, A.P., and M.C. MeYezJ.Phr:i. .Sci., 65 652, (1376).
- United States Pharmacopeia, XIX,(1975),P.650.Ibid,P.83.
- Van Petten, G.R., Becking, G.C., Withey, R.J., and Lettau, H.F. J.Clin.Pharmacol., 11, 35, (1971).